Overview

Dashboard News

icapital reaches 200 billion in global assets enhancing access to private markets

iCapital, a global fintech firm, has surpassed $200 billion in global platform assets, reflecting a significant growth from $100 billion in December 2021. The platform, which connects over 104,000 financial institutions with more than 1,630 funds from 600 asset managers, aims to enhance access to private markets for investors. With a workforce of over 1,675 across 17 locations, iCapital plans to invest over $600 million into its technology and solutions by the end of 2024, while expanding its international presence.
finews.com
United States Dollar UBS SA Icapital AI GP LLC USA Marco Bizzozero
Finance & Economy, Market Report
14:58 09.10.2024

ubs predicts continued gold rally with prices reaching 3000 by 2025

UBS analysts predict a continued rally in gold prices, forecasting they will reach $2,800 by the end of 2024 and $3,000 by 2025. This optimism is driven by strong demand, falling interest rates, a weakening US dollar, and geopolitical tensions, which position gold as a safe haven. Central banks are expected to increase their gold reserves, while consumer demand in major markets like China and India remains stable despite rising prices.
Investing.com France
UBS SA CHN IND USA Show more
TradFi, Market Report
14:46 09.10.2024

ares management to acquire gcp international for 3.7 billion dollars

Ares Management is set to acquire GCP International for $3.7 billion, a move that will nearly double its real estate assets under management to approximately $96 billion. The deal, which includes $1.8 billion in cash, will enhance Ares' global presence and capabilities in high-growth sectors like industrial real estate and data centers. The transaction is expected to close in the first half of 2025.
Institutional Investor
United States Dollar Fitch Ratings Inc. GLP International GLP Capital Partners Ares Management Corporation Oppenheimer Holdings Inc. VNM BRA SGP USA Julie Solomon Michael Arougheti Ming Mei Bill Benjamin Michael Steele Show more
Finance & Economy, Market Report
14:38 09.10.2024

Purespring Therapeutics secures 105 million for kidney gene therapy development

Purespring Therapeutics has secured $105 million in Series B funding to advance its gene therapies for kidney diseases, particularly targeting IgA nephropathy (IgAN). The funding, led by Sofinnova Partners, will support a Phase 1/2 study of its lead candidate, utilizing adeno-associated viruses to deliver treatments aimed at the podocytes, which are linked to many renal diseases. The company plans to present its IgAN data at the upcoming American Society of Nephrology’s Kidney Week meeting.
BioPharma Dive
United States Dollar Vertex Pharmaceuticals Incorporated Novartis AG Julian Hanak
Healthcare, News Article
14:09 09.10.2024

India's Growing Medical Tourism Industry: A New Frontier for Healthcare

India is rapidly emerging as a leading destination for medical tourism, attracting around 150,000 international patients annually, with a projected growth of 15% each year. The government has implemented various initiatives, including the introduction of special visas, accreditation for healthcare facilities, and promotional campaigns to enhance the country's appeal. With a combination of world-class hospitals, skilled professionals, and affordable care, India is poised to become a significant player in the global medical tourism market.
ResearchGate
United States Dollar Apple Inc. Lake Shore India Retail Venture Fund AIMS KIMS-Trivandrum MIMS-Calicut THA IND Show more
Healthcare, Market Report
14:09 09.10.2024

snb key rate cut diminishes value of savings accounts for consumers

The Swiss National Bank's recent key interest rate cut has led to a significant decline in savings account interest rates, with many banks now offering as low as 0.2%. This trend is expected to continue, as further rate cuts may be necessary to maintain price stability, leaving savers with diminishing returns on their deposits.
Econostrum.info Suisse
Swiss Franc Zuger Kantonalbank neon AG Aargauische Kantonalbank BC Genevoise CHE Show more
TradFi, Market Report
13:29 09.10.2024

lilly and insitro forge partnership to advance metabolic disease treatments using ai

Eli Lilly has partnered with AI firm Insitro to advance drug development, focusing on metabolic diseases. The collaboration includes three agreements, allowing Insitro to retain global rights to its research while Lilly benefits from milestone payments and potential royalties. Insitro will utilize Lilly's delivery technology alongside its own innovations to target liver conditions and develop new treatments.
BioPharma Dive
Eli Lilly and Company Bristol-Myers Squibb Company NVIDIA Corporation Gilead Sciences, Inc. Recursion Pharmaceuticals, Inc. USA Show more
Technology & Innovation, News Article
13:29 09.10.2024

microcar market poised for growth driven by demand for smaller vehicles

The global microcar market, valued at $4.53 billion in 2022, is projected to grow at a CAGR of 11.02% from 2023 to 2030, driven by the demand for smaller, cost-effective vehicles amid urban congestion. Electric microcars lead the market share, while Asia Pacific is anticipated to be the fastest-growing region, fueled by a preference for affordable cars in countries like India and Japan. Major players include PSA Group, Smart, Toyota, and Renault, focusing on innovative technologies and sustainable transportation solutions.
Market Research Reporting & Analysis Agency in India
United States Dollar Nissan Motors Co. Ltd. Toyota Motor Company PSA Group Renault S.A. Group General Motors Company Honda Motor Co., Ltd. JPN IND Nissan Motors Co. Ltd. Renault S.A. Group Show more
Finance & Economy, Market Report
13:23 09.10.2024

nobel prize awarded for protein design and drug developments advance

David Baker, Demis Hassabis, and John Jumper have won the Nobel Prize in Chemistry for their groundbreaking work in computational protein design and structure prediction, significantly advancing drug design capabilities. Alnylam Pharmaceuticals seeks FDA approval for vutrisiran to treat a severe form of transthyretin amyloidosis, while Johnson & Johnson halts a bladder cancer trial for TAR-200. AstraZeneca invests in a preclinical cholesterol-lowering drug, and Astellas acquires rights to an experimental gene therapy for frontotemporal dementia.
BioPharma Dive
United States Dollar Eli Lilly and Company AviadoBio Alnylam Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. Amgen Inc. Astellas Pharma Inc. Pfizer Inc. BridgeBio Pharma, Inc. Novartis AG AstraZeneca PLC Johnson & Johnson USA SWE JPN BRA HKG John Jumper David Baker Jonathan Gardner Demis Hassabis Jim Wilson Show more
Healthcare, News Article
13:00 09.10.2024

nvidia shares poised for growth as analysts predict strong seasonal performance

NVIDIA shares are poised for a potential comeback, with analysts maintaining a strong buy recommendation. The stock is currently trading about 15% below the average price target of USD 152.44, with significant growth expected as the seasonal phase strengthens from October 29, historically yielding over 10% gains in the following weeks.
IG
United States Dollar NVIDIA Corporation USA
TradFi, Market Report
12:47 09.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Cryptocurrency & Blockchain Regulations Market Sentiment Analysis Inflation Rates & CPI Data Banking Regulations Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations SEC & Financial Compliance Cryptocurrency Regulations Tokenomics and Crypto Economics Blockchain Technology Adoption Mergers & Acquisitions Market Analysis and Predictions Anti-Money Laundering (AML) Regulations Real Estate Investments Cryptocurrency Developments Banking & Investment Regulations
Countries:
USA CHE CHN GBR JPN CAN HKG ITA SGP IND KOR FRA DEU TUR PRK AUS POL ARE ZAF PHL
Companies:
Coinbase Global, Inc. JPMorgan Chase & Co. Solana USD Apple Inc. MicroStrategy Inc Ripples USD BlackRock, Inc. NVIDIA Corporation Bitwise Bitcoin ETF Grayscale Litecoin Trust Chainlink USD VanEck Vietnam ETF Intesa Sanpaolo KB Home Wells Fargo & Company Ethereum USD Robinhood Markets, Inc. Kraken Energy Corp. Coinbase Global Inc The Goldman Sachs Group, Inc.
Currencies:
United States Dollar Euro Swiss Franc Chinese Yuan British Pound Sterling Canadian Dollar Indian Rupee Japanese Yen Hong Kong Dollar Australian Dollar Thai Baht South Korean Won Swedish Krona Danish Krone Mongolian Tögrög Indonesian Rupiah New Zealand Dollar
People:
Donald Trump Gary Gensler Elon Musk Brad Garlinghouse Paul Atkins Joe Biden Stephanos Bibas Paul Grewal David O. Sacks Michael J. Saylor Ali Martinez Stuart Alderoty Hunter Horsley Changpeng Zhao Peter Brandt Scott Bessent Matthew Sigel Sanjay Shrestha Kevin O'Brien Thomas L. Ambro

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings